(3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine

CAS: 76272-56-5

Ref. 3D-IE22671

Produktinformation

• Name: (3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
• Synonyme: b-3-Amino-9-methyl-9-azabicyclo[3.3.1]nonaneGranisetron impurity E (free base), Endo-3-Amine-9-Methyl-9-Azabicyclo[3,3,1]Nonane, Endo-3-amino-9-methyl-9-azabicyclo[3,3,1]nonane, Endo-9-Methyl-9-Azabicyclo[3,3,1] nonane-3-Amine, 9-Methyl-9-Azabicyclo[3.3.1]Nonan-3-Amine, 9-Methyl-9-Azabicyclo[3.3.1]Nonan-1-Amine

Beschreibung

Granisetron is a drug that belongs to the group of serotonin receptor antagonists. It is used as an antiemetic, mainly in the prevention and treatment of nausea and vomiting caused by cancer chemotherapy and surgery. This drug has been shown to be effective in controlling nausea and vomiting, even when given after chemotherapy or surgical procedures. Granisetron hydrochloride was synthesized in 1988 by chemists at Hoffmann-La Roche. The synthesis was patented in 1990. Potential impurities are not listed on the USP or EP pharmacopeia, but these impurities have been detected during synthesis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 154.25 g/mol
• Formel: C₉H₁₈N₂
• Reinheit: Min. 95%